Serious Treatment Related Adverse Drug Reactions amongst Anti-Retroviral Naïve MDR-TB Patients

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Van der Walt, Martha ^a   Lancaster, Johanna ^a   Odendaal, Ronel ^a   Davis, Jeanne Garcia ^b   Shean, Karen ^a   Farley, Jason ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIRETROVIRUS AGENT; CIPROFLOXACIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; TERIZIDONE; TUBERCULOSTATIC AGENT;

ABSCESS; ADULT; ADVERSE DRUG REACTION; ARTICLE; COHORT ANALYSIS; DEPRESSION; DISEASE SEVERITY; DIZZINESS; DRUG ERUPTION; EARLY DIAGNOSIS; EPILEPSY; FEMALE; GYNECOMASTIA; HEADACHE; HEARING; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INJECTION SITE INFLAMMATION; INJECTION SITE PAIN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; OTOTOXICITY; PATIENT CARE; PROSPECTIVE STUDY; PSYCHOSIS; SECONDARY ANALYSIS; SIDE EFFECT; SOUTH AFRICA; TINNITUS; TREATMENT OUTCOME; TREMOR; VOMITING;

ADULT; ANTITUBERCULAR AGENTS; COINFECTION; CYCLOSERINE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HEARING LOSS; HIV INFECTIONS; HUMANS; ISOXAZOLES; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OFLOXACIN; OXAZOLIDINONES; PROSPECTIVE STUDIES; PSYCHOSES, SUBSTANCE-INDUCED; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84875699280     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058817     Document Type: Article

References (15)

1. Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland GH, et al. (2009) Treatment outcomes among patients with multidrug-resistant tuberculosis: Systematic review and meta-analysis. Lancet Infect Dis 9: 153-161.
2. Sterling TR, Pham PA, Chaisson RE (2010) HIV infection-related tuberculosis: Clinical manifestations and treatment. Clin Infect Dis, Suppl 3: S223-S230.
3. Scano F, Vitoria M, Burman W, Harries AD, Gilks C F, et al. (2008) Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings. Int J Tuberc Lung Dis 12: 1370-1375.
4. World Health Organisation (2008) Guidelines for the programmatic management of drug- resistant tuberculosis: Emergency update 2008. World Health Organisation: Geneva.
5. Shean KP, Willcox PA, Siwendu SN, Laerson KF, Gross L, (2008) Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast/Winelands, South Africa, 1992-2002. Int J Tuberc Lung Dis 12: 1182-1189.
6. Bloss E, Kuksa L, Holtz TH, Riekstina V, Skripconoka V, et al. (2010) Adverse events related to multidrug-resistant tuberculosis treatment, Latvia, 2000-2004. Int J Tuberc Lung Dis 14: 275-281.
7. Nathanson E, Gupta R, Huamani P, Leimane V, Pasechnikov AD, et al. (2004) Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative. Int J Tuberc Lung Dis 8: 1382-1384.
8. Shin SS, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, et al. (2007) Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia. Int J Tuberc Lung Dis 11: 1314-1320.
9. World Health Organisation (2010) Global Tuberculosis Control report.
10. South African Medical Research Council and the DOTS-plus Study Group of South Africa (2000) DOTS-Plus for multi-drug resistant tuberculosis patients in South Africa - Systemic evaluation of a standarised treatment regimen applied under tuberculosis control programme conditions.
11. Weyer K, Brand J, Lancaster J, Levin J, van der Walt M, (2007) Determinants of multidrug-resistant tuberculosis in South Africa: results from a national survey. SA Medical Journal 97: 1120-1128.
12. National Department of Health SA (2010) The South African Antiretroviral Treatment Guidelines 2.
13. Farley JE, Ram M, Pan W, Waldman S, Cassell GH,et al. (2011) Outcomes of Multi-Drug Resistant Tuberculosis (MDR-TB) among a Cohort of South African Patients with High HIV Prevalence. PLOSone 6 1-7.
14. Torun T, Gungor G, Ozmen I, Sevim T, Tahaoglu K, et al. (2005) Side effects associated with the treatment of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 9: 1373-1377.
15. Sagwa E, Mantel-Teeuwisse AK, Ruswa N, Musasa JP, Pal S,et al. (2012) The burden of adverse events during treatment of drug-resistant tuberculosis in Namibia. Southern Med Review Vol 5.